EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Characterization of etoposide-resistant choriocarcinoma cells and contribution of MAPK7 to etoposide resistance

Yuko Yasui, Kosuke Yoshida iD, Yuki Nishiko, Hironori Suzuki, Yusuke Yamamoto, Kazumasa Mogi, Masato Yoshihara, Yukari Nagao, Satoshi Tamauchi, Akira Yokoi, Nobuhisa Yoshikawa, Kimihiro Nishino und 3 weitere

BMC Cancer · 2026

DOI: 10.1186/s12885-026-16640-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMC Cancer, 2026. Verfasst von Yuko Yasui und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Tsuruma-Cho 65, Showa-Ku, Nagoya, 466-8550, Japan. Hauptthemen laut MEDLINE: Etoposide, Drug Resistance, Neoplasm, Choriocarcinoma, Antineoplastic Agents, Phytogenic. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gestational choriocarcinoma is an aggressive gynecologic malignancy that can occur with various pregnancy events. Although typically highly sensitive to combination chemotherapy, this malignancy, in a subset of patients, develops resistance to etoposide-containing regimens, leading to therapeutic failure. We aimed to elucidate the molecular mechanisms that confer resistance to etoposide, a central component of choriocarcinoma chemotherapy.

Methods

Etoposide-resistant JAR and JEG-3 choriocarcinoma cell lines were established by continuous stepwise exposure of parental cells to increasing concentrations of etoposide. Phenotypic comparisons with the parental cells were then performed. RNA sequencing and upstream regulator analyses were conducted to identify key regulatory molecules and signaling pathways associated with etoposide resistance. Candidate molecules were further evaluated by siRNA-mediated knockdown to assess their effects on etoposide sensitivity.

Results

Compared with their parental cells, etoposide-resistant choriocarcinoma cells demonstrated significantly reduced proliferation ( p < 0.001), migration ( p < 0.05), and invasion ( p < 0.01). RNA sequencing and pathway analyses revealed suppression of pathways related to cell cycle progression and DNA replication. In addition, upstream regulator analysis focusing on kinases suggested the involvement of MAPK-related molecules, including MAPK9, MAP2K5, and MAPK7. siRNA-mediated suppression of MAPK7 in resistant cells restored sensitivity to etoposide, suggesting a role for MAPK7 in the maintenance of etoposide resistance.

Conclusion

Our findings indicate that the MAPK signaling pathway, particularly MAPK7, contributes to etoposide resistance in choriocarcinoma, based on RNA sequencing and functional analyses of resistant cell models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EtoposideDrug Resistance, NeoplasmChoriocarcinomaAntineoplastic Agents, PhytogenicUterine NeoplasmsHumansFemaleCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticPregnancyCell Movement

Stichwörter der Autor:innen

ChoriocarcinomaEtoposide-resistantMAPK pathwayMAPK7RNA-seq

Substanzen

EtoposideAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Tsuruma-Cho 65, Showa-Ku, Nagoya, 466-8550, Japan.
  • Department of Obstetrics and Gynecology, Aichi Medical University School of Medicine, Nagakute, Japan.
  • Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Tsuruma-Cho 65, Showa-Ku, Nagoya, 466-8550, Japan. yoshida.kousuke@med.nagoya-u.ac.jp.
  • Institute for Advanced Research, Nagoya University, Nagoya, Japan. yoshida.kousuke@med.nagoya-u.ac.jp.
  • Laboratory of Integrative Oncology, National Cancer Center Research Institute, Tokyo, Japan.
  • Department of Medical Genomics Center, Nagoya University Hospital, Nagoya, Japan.

ORCID-Profile: Kosuke Yoshida

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Yasui, Y., Yoshida, K., Nishiko, Y., Suzuki, H., Yamamoto, Y., Mogi, K., Yoshihara, M., Nagao, Y., Tamauchi, S., Yokoi, A., Yoshikawa, N., Nishino, K., Yamamoto, E., Niimi, K., & Kajiyama, H. (2026). Characterization of etoposide-resistant choriocarcinoma cells and contribution of MAPK7 to etoposide resistance. BMC Cancer. https://doi.org/10.1186/s12885-026-16640-9

Vancouver

Yasui Y, Yoshida K, Nishiko Y, Suzuki H, Yamamoto Y, Mogi K, et al. Characterization of etoposide-resistant choriocarcinoma cells and contribution of MAPK7 to etoposide resistance. BMC Cancer. 2026. doi:10.1186/s12885-026-16640-9

BibTeX
@article{Yasui2026,
  author = {Yasui, Yuko and Yoshida, Kosuke and Nishiko, Yuki and Suzuki, Hironori and Yamamoto, Yusuke and Mogi, Kazumasa and Yoshihara, Masato and Nagao, Yukari and Tamauchi, Satoshi and Yokoi, Akira and Yoshikawa, Nobuhisa and Nishino, Kimihiro and Yamamoto, Eiko and Niimi, Kaoru and Kajiyama, Hiroaki},
  title = {Characterization of etoposide-resistant choriocarcinoma cells and contribution of MAPK7 to etoposide resistance},
  journal = {BMC Cancer},
  year = {2026},
  doi = {10.1186/s12885-026-16640-9}
}
Kostenlos starten →